fbpx

Pancreatic cancer research enhanced through new access to advanced nanotechnology

Australian cancer researchers can now view never-before-seen images of how cancers respond to therapy, thanks to new access to an advanced imaging nanotechnology, based in the US.

Dr Paul Timpson of the Garvan Institute of Medical Research, in collaboration with a team from the UK, are using the Fluroescence Resonance Energy Transfer (FRET) technologies to map areas within pancreatic cancers, pin-pointing where drugs need to be delivered to significantly improve patient survival.

Continue reading “Pancreatic cancer research enhanced through new access to advanced nanotechnology”